News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

D-Pharm Ltd.'s DP-b99 Prevents Abnormal Neuronal Plasticity And Pathological Brain Reorganization


6/12/2014 7:19:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

REHOVOT, Israel, June 12, 2014 /PRNewswire via COMTEX/ -- REHOVOT, Israel, June 12, 2014 /PRNewswire/ --

D-Pharm Ltd. (tase:DPRM) announced today, publication in PLOS ONE, of promising results from a study of its drug candidate DP-b99. The findings suggest that DP-b99 may prevent lasting alterations in neuronal function and pathological brain reorganization - a hallmark of numerous central nervous system (CNS) diseases.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES